Repertoire – September 2021
Metrex’s CaviWipes 2.0, with its new generation of active ingredients, elevates the tried-and-true original CaviWipes to next-level cleaning and disinfection.
CaviWipes 2.0, a one-step, broad-spectrum disinfectant wipe, helps reduce the risk of cross-contamination in healthcare facilities quickly and efficiently – all while addressing common challenges of material compatibility.
The new wipes can quickly and efficiently kill 42 pathogens, including SARS-CoV-2. These quality wipes are used for cleaning and disinfecting hard, non-porous, inanimate surfaces and non-critical instruments in hospitals, laboratories, and other critical care areas.
CaviWipes 2.0 features an easy-to-use label, making it quick and easy to find critical information on efficacy, recommended surfaces, and more. The label includes a categorized and alphabetized organisms claim on the front, clear contact time on both the front and back, and a table to help users more easily identify use sites.
One-Step Cleaning
CaviWipes 2.0 creates synergy between a quaternary ammonium compound with low alcohol to achieve highly effective surface disinfection while maintaining material integrity and resulting in a one-step infection-prevention solution.
This powerful combination means that the CaviWipes 2.0 is effective against pathogens in the presence of a 5% blood soil condition, eliminating the need for a pre-cleaning2 step (disclaimer: when soil is not visible), which would require an additional wipe.
A single-step cleaning process means halving the total amount of wipes needed to get the job done, which frees up space and reduces materials costs. Not only that, but one-step cleaning and disinfecting can facilitate faster turnover and greater compliance.
2-minute Universal Contact Time
CaviWipes 2.0 cleans and disinfects against bacteria, viruses and pathogenic fungi with a 2-minute universal contact time.
A surface disinfectant must stay visibly wet on the surface for the contact time specified in the product’s label to ensure efficacy. For some other products on the market that means a contact time of up to 10 minutes.
Typically, healthcare workers only have a short 40-to-45-minute turnaround time1, so surface disinfectants with longer contact times are a huge constraint. Moreover, long contact times may increase the chance that proper surface disinfection protocols are disregarded for the sake of urgency.
With its quick turnaround time, CaviWipes 2.0 can facilitate faster turnaround time and greater compliance while also reducing the burden on the healthcare workers.
Effective Against 42 Pathogens
CaviWipes 2.0 qualifies for the U.S. Environmental Protection Agency’s (EPA) Emerging Viral Pathogen claim for all virus types (enveloped, large and small non-enveloped viruses3).
CaviWipes 2.0 is on the EPA’s “List N,” and has an efficacy claim against SARS-CoV-2, the virus that causes COVID-19, when used according to label directions4.
Built off the chemistry of the legacy product, CaviWipes, CaviWipes 2.0 is effective against 42 pathogens, including commonly found multi-drug resistant organisms, as well as:
- SARS-CoV-2
- Norovirus
- Candida Auris
- Mycobacterium bovis (TB)
- Methicillin-Resistant Staphylococcus aureus (MRSA)
- Human Immunodeficiency Virus Type 1 (HIV-1)
1 Patient Room Turnover – A Balance of Speed and Quality, August 12, 2021, www.eonsolutions.io/blog/patient-room-turnover-a-balance-of-speed- and-quality
2 Precleaning needed for bloodborne pathogens and candida auris
3 www.epa.gov/coronavirus/what-emerging-viral-pathogen-claim, August 12, 2021
4 List N: Disinfectants for Use Against SARS-CoV-2, August 12, 2021. www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2